SEC Form 4 · accession 0001209191-17-052312
Armata Pharmaceuticals, Inc. · ARMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendy S. Johnson
Director
Period of report
Sep 7, 2017
Accepted (ET)
Sep 11, 2017 · 8:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921114
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.91 | Sep 7, 2017 | A | 10,900 | A | Sep 7, 2018 | Sep 6, 2027 | Common Stock | 10,900 | 10,900 | D |